JP Morgan Chase’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.1K Buy
2,663
+160
+6% +$1.08K ﹤0.01% 6786
2026
Q1
$15.3K Buy
2,503
+11
+0.4% +$68 ﹤0.01% 6630
2025
Q4
$14.3K Buy
+2,492
New +$15.4K ﹤0.01% 6587
2025
Q2
Sell
-28,102
Closed -$151K 7662
2025
Q1
$151K Sell
28,102
-40,850
-59% -$278K ﹤0.01% 5371
2024
Q4
$514K Buy
68,952
+21,494
+45% +$177K ﹤0.01% 5026
2024
Q3
$429K Buy
47,458
+33,929
+251% +$350K ﹤0.01% 4996
2024
Q2
$144K Sell
13,529
-5,781
-30% -$61.6K ﹤0.01% 5334
2024
Q1
$170K Sell
19,310
-46,965
-71% -$382K ﹤0.01% 5429
2023
Q4
$452K Buy
66,275
+25,801
+64% +$212K ﹤0.01% 4864
2023
Q3
$395K Buy
40,474
+40,460
+289,000% +$324K ﹤0.01% 4624
2023
Q2
$68 Hold
14
﹤0.01% 6720
2023
Q1
$0 Hold
14
﹤0.01% 7243
2022
Q4
$0 Hold
14
﹤0.01% 7018
2022
Q3
$0 Hold
14
﹤0.01% 6872
2022
Q2
$0 Hold
14
﹤0.01% 6904
2022
Q1
$0 Hold
14
﹤0.01% 7044
2021
Q4
$0 Sell
14
-534
-97% -$3.28K ﹤0.01% 6974
2021
Q3
$4K Sell
548
-29,163
-98% -$235K ﹤0.01% 6270
2021
Q2
$249K Buy
29,711
+131
+0.4% +$1.13K ﹤0.01% 5120
2021
Q1
$245K Buy
29,580
+2,171
+8% +$15.4K ﹤0.01% 5065
2020
Q4
$177K Buy
27,409
+17,202
+169% +$109K ﹤0.01% 4851
2020
Q3
$63K Buy
10,207
+1,864
+22% +$12.2K ﹤0.01% 4876
2020
Q2
$58K Buy
+8,343
New +$61K ﹤0.01% 4789
2018
Q4
Sell
-19,200
Closed -$156K 5954
2018
Q3
$156K Buy
19,200
+3,808
+25% +$35.6K ﹤0.01% 4777
2018
Q2
$148K Buy
+15,392
New +$148K ﹤0.01% 4693
2017
Q4
Sell
-428
Closed -$3K 5583
2017
Q3
$3K Buy
+428
New +$2.92K ﹤0.01% 4848

Other funds holding ULBI

JP Morgan Chase's ULBI Position: Q2 2026 in Review

JP Morgan Chase increased its Ultralife (ULBI) stake by 6.4% in Q2 2026, buying an estimated $1.08K and bringing the position to 2,663 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6786.

JP Morgan Chase first reported a position in ULBI in Q3 2017 and has held it in 26 quarters since. The position peaked at $514K in Q4 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • JP Morgan Chase held 2,663 shares of Ultralife worth $16.1K as of Q2 2026.
  • JP Morgan Chase bought 160 Ultralife shares in Q2 2026, an estimated $1.08K.
  • Ultralife made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6786 holding.
  • JP Morgan Chase first reported a position in Ultralife in Q3 2017 and has held it in 26 quarters since.
  • JP Morgan Chase's Ultralife position peaked at $514K in Q4 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.